Lee J - Search Results

1

Retracted: Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans.

Bae SH, Park WS, Han S, Park GJ, Lee J, Hong T, Jeon S, Yim DS. Bae SH, et al. Among authors: lee j. Biopharm Drug Dispos. 2017 Jul;38(5):363. doi: 10.1002/bdd.2060. Epub 2017 Feb 6. Biopharm Drug Dispos. 2017. PMID: 28027398

'Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans' by Soo Hyeon Bae, Wan-Su Park, Seunghoon Han, Gab-jin Park, Jongtae Lee, Taegon Hong, Sangil Jeon and Dong-Seok Yim The a …

'Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin …

2

Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans.

Bae SH, Park WS, Han S, Park GJ, Lee J, Hong T, Jeon S, Yim DS. Bae SH, et al. Among authors: lee j. Korean J Physiol Pharmacol. 2018 May;22(3):321-329. doi: 10.4196/kjpp.2018.22.3.321. Epub 2018 Apr 25. Korean J Physiol Pharmacol. 2018. PMID: 29719454 Free PMC article.

3

Pharmacokinetic-pharmacodynamic model of fimasartan applied to predict the influence of a high fat diet on its blood pressure-lowering effect in healthy subjects.

Lee J, Han S, Jeon S, Hong T, Yim DS. Lee J, et al. Eur J Clin Pharmacol. 2013 Jan;69(1):11-20. doi: 10.1007/s00228-012-1297-3. Epub 2012 Jun 2. Eur J Clin Pharmacol. 2013. PMID: 22660441 Clinical Trial.

4

Population pharmacokinetic analysis of colistin in burn patients.

Lee J, Han S, Jeon S, Hong T, Song W, Woo H, Yim DS. Lee J, et al. Antimicrob Agents Chemother. 2013 May;57(5):2141-6. doi: 10.1128/AAC.00271-13. Epub 2013 Feb 25. Antimicrob Agents Chemother. 2013. PMID: 23439640 Free PMC article.

5

Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects.

Hong T, Han S, Lee J, Jeon S, Park GJ, Park WS, Lim KS, Chung JY, Yu KS, Yim DS. Hong T, et al. Among authors: lee j. Drug Des Devel Ther. 2015 Feb 26;9:1233-45. doi: 10.2147/DDDT.S79772. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25750520 Free PMC article.

6

Exposure-response model for sibutramine and placebo: suggestion for application to long-term weight-control drug development.

Han S, Jeon S, Hong T, Lee J, Bae SH, Park WS, Park GJ, Youn S, Jang DY, Kim KS, Yim DS. Han S, et al. Among authors: lee j. Drug Des Devel Ther. 2015 Sep 9;9:5185-94. doi: 10.2147/DDDT.S85435. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26392753 Free PMC article. Clinical Trial.

7

Use of a Target-Mediated Drug Disposition Model to Predict the Human Pharmacokinetics and Target Occupancy of GC1118, an Anti-epidermal Growth Factor Receptor Antibody.

Park WS, Han S, Lee J, Hong T, Won J, Lim Y, Lee K, Byun HY, Yim DS. Park WS, et al. Among authors: lee k, lee j. Basic Clin Pharmacol Toxicol. 2017 Mar;120(3):243-249. doi: 10.1111/bcpt.12675. Epub 2016 Nov 2. Basic Clin Pharmacol Toxicol. 2017. PMID: 27637171 Free article.

8

Comparison of oral absorption models for pregabalin: usefulness of transit compartment model.

Hong T, Han S, Lee J, Jeon S, Yim DS. Hong T, et al. Among authors: lee j. Drug Des Devel Ther. 2016 Dec 7;10:3995-4003. doi: 10.2147/DDDT.S123318. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27994441 Free PMC article.

9

Bortezomib pharmacokinetics in tumor response and peripheral neuropathy in multiple myeloma patients receiving bortezomib-containing therapy.

Lee SE, Choi K, Han S, Lee J, Hong T, Park GJ, Yim DS, Min CK. Lee SE, et al. Among authors: lee j. Anticancer Drugs. 2017 Jul;28(6):660-668. doi: 10.1097/CAD.0000000000000506. Anticancer Drugs. 2017. PMID: 28430745 Clinical Trial.

10

Mixed-effect circadian rhythm model for human erythrocyte acetylcholinesterase activity--application to the proof of concept of cholinesterase inhibition by acorn extract in healthy subjects with galantamine as positive control.

Han S, Lee J, Jeon S, Hong T, Yim DS. Han S, et al. Among authors: lee j. Eur J Clin Pharmacol. 2012 May;68(5):599-605. doi: 10.1007/s00228-011-1192-3. Epub 2011 Dec 30. Eur J Clin Pharmacol. 2012. PMID: 22207414 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142,085 results

Search Page